<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cereb Cortex</journal-id>
<journal-id journal-id-type="iso-abbrev">Cereb. Cortex</journal-id>
<journal-id journal-id-type="publisher-id">cercor</journal-id>
<journal-title-group>
<journal-title>Cerebral Cortex (New York, NY)</journal-title>
</journal-title-group>
<issn pub-type="ppub">1047-3211</issn>
<issn pub-type="epub">1460-2199</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27600849</article-id>
<article-id pub-id-type="pmc">6075453</article-id>
<article-id pub-id-type="doi">10.1093/cercor/bhw194</article-id>
<article-id pub-id-type="publisher-id">bhw194</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Oxygen Levels Regulate the Development of Human Cortical Radial Glia Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ortega</surname>
<given-names>J Alberto</given-names>
</name>
<xref ref-type="aff" rid="bhw194af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sirois</surname>
<given-names>Carissa L</given-names>
</name>
<xref ref-type="aff" rid="bhw194af1">1</xref>
<xref ref-type="aff" rid="bhw194af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Memi</surname>
<given-names>Fani</given-names>
</name>
<xref ref-type="aff" rid="bhw194af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Glidden</surname>
<given-names>Nicole</given-names>
</name>
<xref ref-type="aff" rid="bhw194af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zecevic</surname>
<given-names>Nada</given-names>
</name>
<xref ref-type="aff" rid="bhw194af1">1</xref>
<xref ref-type="corresp" rid="bhw194cor1"></xref>
<!--<email>nzecevic@uchc.edu</email>-->
</contrib>
</contrib-group>
<aff id="bhw194af1">
<label>1</label>
<addr-line>Department of Neuroscience</addr-line>, <institution>University of Connecticut Health</institution>, <addr-line>Farmington, CT 06030</addr-line>, <country>USA</country></aff>
<aff id="bhw194af2">
<label>2</label>
<addr-line>Department of Genetics and Genome Sciences</addr-line>, <institution>University of Connecticut Health Center</institution>, <addr-line>Farmington, CT 06030</addr-line>, <country>USA</country></aff>
<author-notes>
<corresp id="bhw194cor1"><label>*</label>Address correspondence to Nada Zecevic, Department of Neuroscience, University of Connecticut Health, 263 Farmington Avenue, Farmington, CT 06030, USA. Email: <email>nzecevic@uchc.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date iso-8601-date="2016-09-03" pub-type="epub">
<day>03</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>27</volume>
<issue>7</issue>
<fpage>3736</fpage>
<lpage>3751</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>5</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>29</day>
<month>4</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>5</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Published by Oxford University Press 2016.</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="us-gov">
<license-p>This work is written by (a) US Government employee(s) and is in the public domain in the US.</license-p>
</license>
</permissions>
<self-uri xlink:href="bhw194.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>The oxygen (O<sub>2</sub>) concentration is a vital parameter for controlling the survival, proliferation, and differentiation of neural stem cells. A prenatal reduction of O<sub>2</sub> levels (hypoxia) often leads to cognitive and behavioral defects, attributable to altered neural development. In this study, we analyzed the effects of O<sub>2</sub> levels on human cortical progenitors, the radial glia cells (RGCs), during active neurogenesis, corresponding to the second trimester of gestation. Small changes in O<sub>2</sub> levels profoundly affected RGC survival, proliferation, and differentiation. Physiological hypoxia (3% O<sub>2</sub>) promoted neurogenesis, whereas anoxia (&lt;1% O<sub>2</sub>) and severe hypoxia (1% O<sub>2</sub>) arrested the differentiation of human RGCs, mainly by altering the generation of glutamatergic neurons. The in vitro activation of Wnt-β-catenin signaling rescued the proliferation and neuronal differentiation of RGCs subjected to anoxia. Pathologic hypoxia (≤1% O<sub>2</sub>) also exerted negative effects on gliogenesis, by decreasing the number of O4<sup>+</sup> preoligodendrocytes and increasing the number of reactive astrocytes derived from cortical RGCs. O<sub>2</sub>-dependent alterations in glutamatergic neurogenesis and oligodendrogenesis can lead to significant changes in cortical circuitry formation. A better understanding of the cellular effects caused by changes in O<sub>2</sub> levels during human cortical development is essential to elucidating the etiology of numerous neurodevelopmental disorders.</p>
</abstract>
<kwd-group>
<kwd>cerebral cortex</kwd>
<kwd>cortical neurogenesis</kwd>
<kwd>hypoxia</kwd>
<kwd>neural stem cells</kwd>
<kwd>Wnt-β-catenin</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>R01 NSO41489</award-id>
<award-id>5R01DA023999-07</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Joint MRC/Welcome Trust</named-content>
<named-content content-type="funder-identifier">10.13039/100004440</named-content>
</funding-source>
<award-id>099175/Z/12/Z</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Advanced Bioscience Resources</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="16"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>